Literature DB >> 13754914

[The electroretinogram and adaptation capacity in retinitis pigmentosa-with a contribution to the theory of the extinguished ERG].

J KUEPER, W MUELLER-LIMMROTH.   

Abstract

Entities:  

Keywords:  ADAPTATION, OCULAR; ELECTRORETINOGRAPHY; RETINITIS PIGMENTOSA/physiology

Mesh:

Year:  1960        PMID: 13754914     DOI: 10.1007/bf00681924

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Ophthalmol        ISSN: 0376-0200


× No keyword cloud information.
  27 in total

1.  [Differential diagnostic significance of electroretinogram in tapeto-retinal degeneration].

Authors:  A FRANCESCHETTI; P DIETERLE
Journal:  Bibl Ophthalmol       Date:  1957

2.  Familial electroretinographic and adaptometric studies in retinitis pigmentosa.

Authors:  G GOODMAN; R D GUNKEL
Journal:  Am J Ophthalmol       Date:  1958-09       Impact factor: 5.258

3.  The differential diagnosis of tapetoretinal degenerations.

Authors:  J FRANCOIS
Journal:  AMA Arch Ophthalmol       Date:  1958-01

4.  Metabolic injuries of the visual cell.

Authors:  W K NOELL
Journal:  Am J Ophthalmol       Date:  1955-11       Impact factor: 5.258

5.  [Visual function in age-related degeneration of the retinal pigment epithelium (tapetum nigrum)].

Authors:  J FRANCOIS; G VERRIEST; A DE ROUCK
Journal:  Bibl Ophthalmol       Date:  1956

6.  The origin of the electroretinogram.

Authors:  W K NOELL
Journal:  Am J Ophthalmol       Date:  1954-07       Impact factor: 5.258

7.  [The importance of electroretinography (ERG) for the differential diagnosis between primary and secondary tapetoretinal degeneration].

Authors:  P DIETERLE
Journal:  Ophthalmologica       Date:  1954 Apr-May       Impact factor: 3.250

8.  [The human electroretinogram during dark adaptation].

Authors:  W BEST
Journal:  Acta Ophthalmol (Copenh)       Date:  1953

9.  [Electroretinogram of the achromate].

Authors:  V VUKOVICH
Journal:  Ophthalmologica       Date:  1952-12       Impact factor: 3.250

10.  Electrophysiologic study of the retina during metabolic impairment.

Authors:  W K NOELL
Journal:  Am J Ophthalmol       Date:  1952-05       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.